What every pharma team should know about artwork management today

Pharmaceutical packaging artwork is one of the most complex and regulated areas of the packaging world. Every carton, leaflet, label, blister, and insert must meet strict industry standards to protect patient safety — and even the smallest artwork error can lead to costly recalls, regulatory scrutiny, and risks to public health.

As pharma companies accelerate global launches and navigate frequent regulatory updates, manual artwork processes simply can’t keep up. A dedicated artwork management system (AMS) like Cway helps teams streamline workflows, maintain compliance, and eliminate risks that traditional tools cannot solve.

Below, we explore the major roadblocks in pharmaceutical artwork management and how Cway helps companies overcome them with automation, lifecycle visibility, and traceability.

3 Common Roadblocks in Pharma Artwork Management

1. Chaotic Submission & Commercial Artwork Workflows

Pharma artwork workflows are inherently complex. They require coordination across:

• regulatory teams

• quality teams

• external agencies

• manufacturing sites

• packaging development

• supply chain partners

Without a centralized system, these workflows become fragmented and error-prone.

Common issues include:

Chaotic processes & communication gaps

Teams rely on emails, spreadsheets, shared drives, or manual folder structures — none of which offer real traceability.

Manual tasks

Manual proofreading, copy updates, version checks, and routing introduce human error and delay approval cycles.

Strict timelines

Delays in artwork approval can directly impact regulatory submissions, production dates, and product availability.

Regulatory compliance pressure

Packaging artwork must adhere to FDA, EMA, MHRA, and other regional guidelines — and every change must be traceable.

Cway solves this by providing a single, audit-ready workflow that ensures every stakeholder sees the right file, at the right time, with complete version accuracy.

2. Inability to Track Regulatory Changes Across Artwork

Pharma artwork is frequently impacted by:

• updated ingredient lists

• label claims

• safety warnings

• excipient disclosures

• dosage updates

• regional market requirements

Each change must be tracked meticulously — often with a corresponding change control number.

Without integration and automation, this becomes a costly challenge.

The risks of disconnected systems:

• missed regulatory deadlines

• mismatched or outdated content

• non-compliant artwork sent to production

• increased risk of recalls

• unclear ownership and change history

3. Difficulty Managing Regulatory Deadlines

Pharma regulations are time-sensitive — most changes must be implemented within 3 to 6 months, and multiple deadlines must be tracked:

• Regulatory Required Date

• Effective Date

• First Production Date

Missing these dates can disrupt supply, trigger warnings from authorities, or force costly rework.

Tracking these milestones manually is not sustainable.

Cway automates deadline tracking, sends reminders, and ensures all teams stay aligned, reducing the risk of non-compliance and launch delays.

Overcoming Pharma Artwork Management Challenges With Cway

Now that the core challenges are clear, it’s evident that pharmaceutical companies require a dedicated system designed to support compliance-heavy artwork workflows.

Cway empowers pharma teams by providing:

Complete Traceability & Version Control

Accurate version tracking is essential for preventing mix-ups and proving compliance.

Cway provides:

• automatic version control

• full audit trails

• access to historical versions

• controlled approval flows

• role-based access

Teams always work with the correct version — never outdated files.

Cway helps teams manage submissions and commercial artwork in one place, so everyone can work together smoothly from concept to final artwork.

Faster Time-to-Market Through Automation

Manual artwork processes slow down launches and introduce unnecessary risk.

Cway accelerates timelines by:

• proofing and review process optimisation

• precise artwork comparison

• workflow automation

• reminders & notifications

This significantly reduces cycle time and helps pharma companies deliver critical products to market faster — without compromising safety or accuracy.

Conclusion

In the highly regulated world of pharmaceutical packaging, accuracy and compliance are non-negotiable. Manual artwork processes cannot provide the control or traceability required at scale.

Cway gives pharma companies a modern, automated artwork management system that:

• enhances compliance

• reduces human error

• accelerates approvals

• ensures traceability

• supports complex multi-market workflows

• improves speed-to-market

By centralizing the entire artwork lifecycle, pharma teams can confidently navigate regulatory demands and ensure that life-saving medicines reach patients safely and on time.

Explore Cway today and discover how it transforms your pharma artwork workflow.